Literature DB >> 25727169

A comparison of routine, opt-out HIV screening with the expected yield from physician-directed HIV testing in the ED.

Matthew E Prekker1, Brandi M Gary2, Roma Patel2, Travis Olives2, Brian Driver2, Stephen J Dunlop2, James R Miner2, Sarah Gordon3, Ronald Schut4, Richard O Gray2.   

Abstract

OBJECTIVES: The Centers for Disease Control and Prevention recommends routine opt-out HIV screening in health care settings. Our goal was to evaluate the feasibility and yield of this strategy in the emergency department (ED) and to compare it to the expected yield of physician-directed testing.
METHODS: This is a cross-sectional study in an urban ED during random shifts over 1 year. Patients were ineligible for screening if they were younger than 18 years or older than 64, a prisoner, a victim of sexual assault, in an ED resuscitation room, or had altered mental status. Research associates administered rapid HIV tests and conducted standardized interviews. The patients' ED physician, blinded to the HIV result, was asked if they would have ordered a rapid HIV test if it had been available.
RESULTS: Of 7756 ED patients, 3957 (51%) were eligible for HIV screening, and 2811 (71%) of those did not opt out. Routine testing yielded 9 new HIV cases (0.32% of those tested; 95% confidence interval, 0.16%-0.63%). Physician-directed testing would have missed most of these infections: 2 of the 785 patients identified by physicians for testing would have been newly diagnosed with HIV (0.25%; 95% confidence interval, 0.04%-1.0%). Of the 9 new HIV cases, 5 established HIV care, and their median CD4 count was 201 cells/μL (range, 71-429 cells/μL).
CONCLUSIONS: Routine opt-out HIV screening was feasible and accepted by a majority of ED patients. The yield of this strategy only modestly exceeded what may have been observed with physician-directed testing.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25727169     DOI: 10.1016/j.ajem.2014.12.057

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

1.  Using the electronic medical record to increase testing for HIV and hepatitis C virus in an Appalachian emergency department.

Authors:  Carmen N Burrell; Melinda J Sharon; Stephen Davis; Judith Feinberg; Elena M Wojcik; Julia Nist; Owen Lander; Valerie Boley; Justin Burns; Ian B K Martin
Journal:  BMC Health Serv Res       Date:  2021-05-29       Impact factor: 2.655

2.  Universal HIV and Birth Cohort HCV Screening in San Diego Emergency Departments.

Authors:  Martin Hoenigl; Kushagra Mathur; Jill Blumenthal; Jesse Brennan; Miriam Zuazo; Melanie McCauley; Lucy E Horton; Gabriel A Wagner; Sharon L Reed; Gary M Vilke; Christopher J Coyne; Susan J Little
Journal:  Sci Rep       Date:  2019-10-09       Impact factor: 4.379

3.  A need for implementation science to optimise the use of evidence-based interventions in HIV care: A systematic literature review.

Authors:  Joseph Cox; Cassidy Gutner; Nadine Kronfli; Anna Lawson; Michele Robbins; Lisette Nientker; Amrita Ostawal; Tristan Barber; Davide Croce; David Hardy; Heiko Jessen; Christine Katlama; Josep Mallolas; Giuliano Rizzardini; Keith Alcorn; Michael Wohlfeiler; Eric Le Fevre
Journal:  PLoS One       Date:  2019-08-19       Impact factor: 3.240

4.  Australian health care providers' views on opt-out HIV testing.

Authors:  Stacy Leidel; Ruth McConigley; Duncan Boldy; Sally Wilson; Sonya Girdler
Journal:  BMC Public Health       Date:  2015-09-14       Impact factor: 3.295

5.  HIV screening in the emergency department: Thoughts on disparities and the next step in ending the epidemic.

Authors:  Jason Haukoos; Emily Hopkins
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-08-28

6.  Opt-out universal HCV and HIV screening in a Canadian emergency room: a cross-sectional study.

Authors:  Valerie Martel-Laferriere; Jean-Guy Baril; Isabelle Alarie; Judith Leblanc; José Côté; Emmanuelle Jourdenais; Damy Horth; Gilles Lambert; Cécile Tremblay
Journal:  BMJ Open       Date:  2022-01-18       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.